Contact
searchSearch
HMP Global

Podcasts

Podcasts
Emily Johnson, MD, on Late-Onset Epilepsy
01/24/2019
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.
Dr Emily Johnson from Johns...
01/24/2019
Neurology
Podcasts
Marcel Daadi, PhD, on Dopaminergic Neurons for Treating Parkinson Disease
01/11/2019
Marcel Daadi, PhD, from Texas Biomedical Research Institute, talks about his life-long research into dopaminergic neurons for treating Parkinson disease and whether it is possible to replenish dopamine loss in the brain.
Marcel Daadi, PhD, from Texas Biomedical Research Institute, talks about his life-long research into dopaminergic neurons for treating Parkinson disease and whether it is possible to replenish dopamine loss in the brain.
Marcel Daadi, PhD, from Texas...
01/11/2019
Neurology
Podcasts
Unpacking Schizophrenia: Preventing Suicides
01/08/2019
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses suicidality in patients with schizophrenia compared with the general population. He also outlines steps...
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses suicidality in patients with schizophrenia compared with the general population. He also outlines steps...
In the final installment of this...
01/08/2019
Neurology
Podcasts
Unpacking Schizophrenia: Why a Global Health Approach Is Key
12/27/2018
In part 3 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in addition to their psychiatric health.
In part 3 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in addition to their psychiatric health.
In part 3 of this podcast...
12/27/2018
Neurology
Podcasts
Unpacking Schizophrenia: The Role of Clozapine and Shattering the Stigma
12/18/2018
Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of this podcast series, Dr Laitman explains how his approach to treatment has helped the majority of his patients...
Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of this podcast series, Dr Laitman explains how his approach to treatment has helped the majority of his patients...
Schizophrenia is not a death...
12/18/2018
Neurology
Podcasts
Unpacking Schizophrenia: Making the Diagnosis
12/16/2018
In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential diagnosis.
In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential diagnosis.
In part 1 of this podcast...
12/16/2018
Neurology
Podcasts
The Risks of Stopping MS Disease-Modifying Therapies
11/14/2018
Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.
Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.
Ilya Kister, MD, from NYU...
11/14/2018
Neurology
Podcasts
Using the GAD-2 for Screening Anxiety in Patients With MS
11/06/2018
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
Dr Abbey Hughes from Johns...
11/06/2018
Neurology
Podcasts
Why Does Autism Affect Boys and Girls So Differently?
07/31/2018
Dr Chiara Manzini, from the George Washington University Institute for Neuroscience, shares insight from her research into the physiologic and genetic mechanisms behind why neurodevelopmental disorders such as autism are more prevalent in the...
Dr Chiara Manzini, from the George Washington University Institute for Neuroscience, shares insight from her research into the physiologic and genetic mechanisms behind why neurodevelopmental disorders such as autism are more prevalent in the...
Dr Chiara Manzini, from the...
07/31/2018
Neurology
Podcasts
Progressive vs Relapsing MS
07/23/2018
Dr Bardia Nourbakhsh from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Dr Bardia Nourbakhsh from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Dr Bardia Nourbakhsh from Johns...
07/23/2018
Neurology

News

a neurologist reviews a brain model with a patient
News
Daytime Sleepiness Linked With Predementia Syndrome in Older Adults
12/10/2024
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related...
12/10/2024
Neurology
Regular Physical Activity After Dementia Diagnosis May Lower Mortality Risk
News
Regular Physical Activity After Dementia Diagnosis May Lower Mortality Risk
11/21/2024
Regular physical activity (PA) following dementia diagnosis could lower the risk of all-cause mortality, according to results from a retrospective cohort study published in the British Journal of Sports Medicine.
Regular physical activity (PA) following dementia diagnosis could lower the risk of all-cause mortality, according to results from a retrospective cohort study published in the British Journal of Sports Medicine.
Regular physical activity (PA)...
11/21/2024
Psych Congress Network
neurology brain stress
News
Targeted Lucidity Reactivation May Help Ease Narcolepsy-Related Nightmares
11/18/2024
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of...
11/18/2024
Neurology
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
News
Risk of Cardiovascular Disease May be Easing in Patients With PsA
11/08/2024
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower...
11/08/2024
Rheumatology & Arthritis
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use